Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterase-sensitive cross-linker in patients with advanced malignancies: a Phase I study

Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterase-sensitive cross-linker in patients with advanced malignancies: a Phase I study

Romain Coriat,1 Sandrine J Faivre,2 Olivier Mir,3 Chantal Dreyer,2 Stanislas Ropert,3 Mohammed Bouattour,2 Robert Desjardins,4 François Goldwasser,3 Eric Raymond5 1Gastroenterology and Digestive Oncology Unit, Cochin Teaching Hospital, Université Paris Descartes Sorbonne Paris...

Full description

Bibliographic Details
Main Authors: Coriat R, Faivre SJ, Mir O, Dreyer C, Ropert S, Bouattour M, Desjardins R, Goldwasser F, Raymond E
Format: Article
Language:English
Published: Dove Medical Press 2016-11-01
Series:International Journal of Nanomedicine
Subjects:
Phase I
topoisomerase I inhibitor
Irinotecan
Fluorescence HPLC.
Online Access:https://www.dovepress.com/pharmacokinetics-and-safety-of-dts-108-a-human-oligopeptide-bound-to-s-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/pharmacokinetics-and-safety-of-dts-108-a-human-oligopeptide-bound-to-s-peer-reviewed-article-IJN

Similar Items